Open access
Aug 2026
Modelling anti-Ov16 seroprevalence for the control and elimination of onchocerciasis
The World Health Organization aims to verify elimination of onchocerciasis transmission in 12 endemic countries by 2030. Serological assays detecting IgG4 antibodies against the Onchocerca volvulus Ov16 antigen guide decision-making regarding start- and stop-mass ivermectin treatment, post-treatment and post-eliminatio...
Aditya Ramani, J. N. Stapley, Matthew A. Dixon et al.
· Nature Communications · 0 citations